Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 3Large-scale testing
1(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (100.0%)

Trials by Status

completed480%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruiting

Determination of Lipocalin Type-prostaglandin (L-PGDS) in Blood, Urine, Vaginal Samples and Endometrial Ablation by Enzyme-linked Immunosorbent Assay

NCT06864494
completed

Clinical Predictive Factors of Success of Hysteroscopic Endometrial Ablation/Resection

NCT05483348
completed

Patient Centered Results for Uterine Fibroids

NCT02260752
completed

Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids

NCT02819609
completedphase_3

Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB)

NCT00114088

Clinical Trials (5)

Showing 5 of 5 trials
NCT06864494

Determination of Lipocalin Type-prostaglandin (L-PGDS) in Blood, Urine, Vaginal Samples and Endometrial Ablation by Enzyme-linked Immunosorbent Assay

Recruiting
NCT05483348

Clinical Predictive Factors of Success of Hysteroscopic Endometrial Ablation/Resection

Completed
NCT02260752

Patient Centered Results for Uterine Fibroids

Completed
NCT02819609

Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids

Completed
NCT00114088Phase 3

Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB)

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5